IRON Stock Analysis: Buy, Sell, or Hold?
IRON - Disc Medicine, Inc. Common Stock
$61.07
0.98 (1.63%)
▲
5d:
+3.32%
30d:
-8.33%
90d:
-23.98%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Accumulation
IRON is down 9.3% this week, but smart money is accumulating calls. Top strike: $90 2026-03-20 with 21 OI. Call ratio: 100% View Scanner →
Strength: 9.7/10
Get Alerted When IRON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IRON shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: IRON shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: IRON is currently trading at $61.07, which is considered fair relative to its 30-day fair value range of $59.54 to $65.16.
Technical Outlook: Technically, IRON is in a strong downtrend. Immediate support is located at $57.72, while resistance sits at $63.27.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $100.17 (+66.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IRON is in a strong downtrend. Immediate support is located at $57.72, while resistance sits at $63.27.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $100.17 (+66.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$59.54 -
$65.16
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 66.7% below Wall St target ($100.17)
Fair Price Analysis
30-Day Fair Range
$59.54 -
$65.16
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$5.32
(8.7%)
Support & Resistance Levels
Support Level
$57.72
Resistance Level
$63.27
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.00
Wall Street Target
$100.17
(+66.7%)
Share & Embed Analysis
Last updated: March 30, 2026 10:26 AM ET
Data refreshes hourly during market hours. Next update: 11:26 AM
Data refreshes hourly during market hours. Next update: 11:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
William Jacob Savage
SELL
7378 shares
2026-03-02
Jean M Franchi
SELL
353 shares
2026-02-25
Jean M Franchi
SELL
7081 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 56 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 60 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 61 BUY |
Advanced IRON Option Strategies
Professional options setups generated by AI based on today's IRON price and gamma walls.
